Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis

Journal of Dermatology

Volumn 43, Issue 3, 2016, Pages 305-310

  Kim, Dae Suk ^a   Shin, Dongyun ^a   Lee, Min Seok ^a   Kim, Hee Ju ^a   Kim, Do Young ^a   Kim, Soo Min ^b   Lee, Min Geol ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

inflammation; neutrophil to lymphocyte ratio; platelet to lymphocyte ratio; psoriasis vulgaris; psoriatic arthritis

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EOSINOPHIL COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; KOREAN (PEOPLE); LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PLATELET LYMPHOCYTE RATIO; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; NEUTROPHIL; PATHOLOGY; PSORIASIS;

ARTHRITIS, PSORIATIC; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; LEUKOCYTE COUNT; NEUTROPHILS; PLATELET COUNT; PSORIASIS; RETROSPECTIVE STUDIES;

EID: 84941886039     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13061     Document Type: Article

References (34)

1. Christophers E,. Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 314-320.
2. Gottlieb A, Korman NJ, Gordon KB, et al,. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 2008; 58: 851-864.
3. Villanova F, Di Meglio P, Nestle FO,. Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis 2013; 72 (Suppl 2): ii104-ii110.
4. Perera GK, Di Meglio P, Nestle FO,. Psoriasis. Annu Rev Pathol 2012; 7: 385-422.
5. Tamhane UU, Aneja S, Montgomery D, et al,. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008; 102: 653-657.
6. Ayca B, Akin F, Celik O, et al,. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Platelets 2014; 28: 1-7.
7. Torun S, Tunc BD, Suvak B, et al,. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol 2012; 36: 491-497.
8. Balta S, Ozturk C,. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets 2014; doi: 10.3109/09537104.2014.979340.
9. Boyraz I, Koc B, Boyaci A, et al,. Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF. Int J Clin Exp Med 2014; 7: 2912-2915.
10. Templeton AJ, McNamara MG, Seruga B, et al,. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106: dju124.
11. Peng W, Li C, Zhu WJ, et al,. Prognostic value of the platelet to lymphocyte ratio change in liver cancer. J Surg Res 2015; 194: 464-470.
12. Balta S, Celik T, Mikhailidis DP, et al,. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost 2015; doi: 10.1177/1076029615569568.
13. Sen BB, Rifaioglu EN, Ekiz O, et al,. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol 2014; 33: 223-227.
14. Ataseven A, Bilgin AU, Kurtipek GS,. The importance of neutrophil lymphocyte ratio in patients with psoriasis. Mater Sociomed 2014; 26: 231-233.
15. Yurtdas M, Yaylali YT, Kaya Y, et al,. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis. Echocardiography 2014; 31: 1095-1104.
16. Taylor W, Gladman D, Helliwell P, et al,. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673.
17. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al,. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004; 150: 917-928.
18. Orem A, Deger O, Cimsit G, et al,. Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis. Clin Chim Acta 1997; 264: 49-56.
19. Mee JB, Cork MJ, di Giovine FS, et al,. Interleukin-1: a key inflammatory mediator in psoriasis? Cytokine 2006; 33: 72-78.
20. Michaelsson G, Kraaz W, Gerden B, et al,. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma. Br J Dermatol 1996; 135: 371-378.
21. Schopf RE, Hultsch T, Lotz J, et al,. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A. J Eur Acad Dermatol Venereol 1998; 11: 234-239.
22. Weiss G, Goodnough LT,. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
23. Furst DE, Kay J, Wasko MC, et al,. The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Rheumatology (Oxford) 2013; 52: 1845-1855.
24. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al,. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 2004; 150: 232-244.
25. Kasperska-Zajac A, Brzoza Z, Rogala B,. Platelet function in cutaneous diseases. Platelets 2008; 19: 317-321.
26. Kim DS, Lee J, Kim SH, et al,. Mean platelet volume is elevated in patients with psoriasis vulgaris. Yonsei Med J 2015; 56: 712-718.
27. Tamagawa-Mineoka R, Katoh N, Ueda E, et al,. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4. Allergol Int 2008; 57: 391-396.
28. Anandarajah AP, Ritchlin CT,. The diagnosis and treatment of early psoriatic arthritis. Nat Rev Rheumatol 2009; 5: 634-641.
29. Gladman DD, Shuckett R, Russell ML, et al,. Psoriatic arthritis (PSA)-an analysis of 220 patients. Q J Med 1987; 62: 127-141.
30. Balta I, Balta S, Demirkol S, et al,. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis. Echocardiography 2014; 31: 1166-1167.
31. Bhat T, Teli S, Rijal J, et al,. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013; 11: 55-59.
32. Eder L, Thavaneswaran A, Chandran V, et al,. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis. Ann Rheum Dis 2014; doi: 10.1136/annrheumdis-2014-205267.
33. Chandran V, Cook RJ, Edwin J, et al,. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford) 2010; 49: 1399-1405.
34. Ogdie A, Yu Y, Haynes K, et al,. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 2015; 74: 326-332.